The New York Times - December 5, 2023
Jelena Pavlovic, M.D., Ph.D., talks about the link between estrogen levels and migraine in women, noting that the start and timing of headaches for many women is connected with a drop in their estrogen, which occurs before and during menstruation. Dr. Pavolovic is associate professor in the Saul R. Korey Department of Neurology at Einstein and a neurologist at Montefiore.
Dr. Pavlovic's Profile
Live Science - December 1, 2023
Anjali Sharma, M.D., M.S., says access to antiretroviral therapy for HIV/AIDS, particularly for young people, and support systems for those on treatment are essential to ending the global AIDS epidemic. Dr. Sharma is professor of medicine at Einstein and an internist at Montefiore.
Dr. Sharma's Profile
NPR - November 29, 2023
Rahil Briggs, Psy.D., and Kevin Fiori, M.D., M.P.H., M.S., discuss the importance of HealthySteps, a program that supports low-income parents' psychological and social needs. Dr. Briggs is clinical professor of pediatrics and psychiatry & behavioral sciences at Einstein and national director of HealthySteps. Dr. Fiori is associate professor of pediatrics and of family & social medicine at Einstein and a pediatrician and director, social determinants of health, in the office of community & population health at Montefiore.
Dr. Briggs' ProfileMore coverage on Dr. Briggs
Dr. Fiori's Profile
Fortune - November 16, 2023
Nir Barzilai, M.D., and Sofiya Milman, M.D., M.S., describe their SuperAgers Family Study, which seeks to discover genes that contribute to healthy aging. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore. Dr. Milman is associate professor of medicine and of genetics and director of Human Longevity Studies at Einstein’s Institute for Aging Research and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Dr. Milman's ProfileMore coverage on Dr. Milman
NPR - October 30, 2023
Gary Schwartz, Ph.D., describes how GLP-1, a hormone that is released during digestion, acts to stimulate insulin and slow how quickly food moves through the stomach into the intestine. Dr. Schwartz is professor of medicine and of psychiatry and behavioral sciences and in the Dominick P. Purpura Department of Neuroscience at Einstein.
Dr. Schwartz's ProfileMore coverage on Dr. Schwartz
MedPageToday - October 16, 2023
Sriram Machineni, M.B.B.S., comments on the results of a study he co-authored on the effectiveness of a phase III trial for tirzepatide, a weight loss drug, which helped study participants lose a significant amount of weight following a diet and exercise program. Dr. Machineni is associate professor of medicine and director of the Fleischer Institute Medical Weight Center at Einstein and Montefiore.
Additional coverage includes Medscape
Dr. Machineni's Profile
US News & World Report - October 16, 2023
Tracey Straker, M.D., comments on a study that found high-risk surgeries are more deadly for Black and Hispanic Americans than their white counterparts, noting that social determinants of health, such as lack of insurance, play a role in the disparities. Dr. Straker is professor and chief of anesthesiology at Einstein and Montefiore.
Dr. Straker's ProfileMore coverage on Dr. Straker
Medscape - October 12, 2023
Belinda Ostrowsky, M.D., says wastewater monitoring of viruses and other seasonal illnesses can be helpful to local public health officials, clinicians, and hospital systems because it provides insight into viral trends at the community level. Dr. Ostrowsky is clinical associate professor of medicine at Einstein.
Dr. Ostrowsky's ProfileMore coverage on Dr. Ostrowsky
USA Today - October 1, 2023
Shivani Agarwal, M.D., M.P.H., discusses a study she led that found structural issues, such as poverty, racism, and unequal access to healthy food and high-quality medical care, contribute to the high rates of diabetes around the world. Dr. Agarwal is associate professor of medicine and associate director of the Fleischer Institute for Diabetes and Metabolism at Einstein and an endocrinologist at Montefiore.
Dr. Agarwal's ProfileMore coverage on Dr. Agarwal
Fox5 - September 28, 2023
Shelby Freedman Harris, Psy.D., says muscle relaxation, deep breathing, keeping a regular sleep schedule, and having a relaxing bedtime routine may help improve sleep quality and quantity. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein.
Dr. Harris' ProfileMore coverage on Dr. Harris
The Washington Post - September 26, 2023
Jonathan Alpert, M.D., Ph.D., warns against self-medicating with psychedelics for depression or other mental health disorders, noting that patients need to be evaluated and under the care of trained providers if psychedelics are used in their treatment. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.
Dr. Alpert's ProfileMore coverage on Dr. Alpert
MedPageToday - September 22, 2023
Jill Crandall, M.D., a member of the FDA's Endocrinologic and Metabolic Drugs Advisory Committee, explains that she voted against approving an implant device for type 2 diabetes in part because patient data weren't consistent regarding the device's delivery of a GLP-1 agonist drug. Dr. Crandall is professor of medicine and the Jacob A. and Jeanne E. Barkey Chair in Medicine at Einstein, and chief of endocrinology at Einstein and Montefiore.
Dr. Crandall's ProfileMore coverage on Dr. Crandall
NPR - September 21, 2023
Jonathan Alpert, M.D., Ph.D., says patients using drugs like Ozempic and Wegovy, commonly prescribed for diabetes, should talk to their doctors about any mental health issues they may be experiencing while taking the medications. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.
Dr. Alpert's ProfileMore coverage on Dr. Alpert
The Philadelphia Inquirer - August 24, 2023
Sofiya Milman, M.D., M.S., describes the SuperAgers Family Study, which seeks to discover drivers of healthy longevity in people over the age of 95. Dr. Milman is associate professor of medicine and of genetics and director of Human Longevity Studies at Einstein’s Institute for Aging Research and an endocrinologist at Montefiore.
Additional coverage includes CNBC and Fox32 Chicago
Dr. Milman's ProfileMore coverage on Dr. Milman